Form 8-K - Current report:
SEC Accession No. 0001213900-14-004119
Filing Date
2014-06-11
Accepted
2014-06-11 08:47:42
Documents
1
Period of Report
2014-06-11
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k060914_actiniumpharma.htm 8-K 90530
  Complete submission text file 0001213900-14-004119.txt   91650
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 14903591
SIC: 6770 Blank Checks